nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—SLC25A4—peripheral nervous system—Parkinson's disease	0.048	0.103	CbGeAlD
Clodronate—SLC25A6—hindbrain—Parkinson's disease	0.0344	0.0734	CbGeAlD
Clodronate—SLC25A6—embryo—Parkinson's disease	0.0215	0.0459	CbGeAlD
Clodronate—SLC25A6—brainstem—Parkinson's disease	0.0197	0.0421	CbGeAlD
Clodronate—SLC25A6—forebrain—Parkinson's disease	0.019	0.0406	CbGeAlD
Clodronate—SLC25A5—embryo—Parkinson's disease	0.0187	0.0399	CbGeAlD
Clodronate—SLC25A5—forebrain—Parkinson's disease	0.0165	0.0353	CbGeAlD
Clodronate—SLC25A6—cardiovascular system—Parkinson's disease	0.0161	0.0343	CbGeAlD
Clodronate—SLC25A4—forebrain—Parkinson's disease	0.0155	0.0331	CbGeAlD
Clodronate—SLC25A5—cardiovascular system—Parkinson's disease	0.014	0.0299	CbGeAlD
Clodronate—SLC25A4—cardiovascular system—Parkinson's disease	0.0131	0.028	CbGeAlD
Clodronate—SLC25A6—spinal cord—Parkinson's disease	0.0123	0.0262	CbGeAlD
Clodronate—SLC25A5—medulla oblongata—Parkinson's disease	0.012	0.0255	CbGeAlD
Clodronate—SLC25A4—medulla oblongata—Parkinson's disease	0.0112	0.0239	CbGeAlD
Clodronate—SLC25A5—midbrain—Parkinson's disease	0.0109	0.0233	CbGeAlD
Clodronate—SLC25A6—head—Parkinson's disease	0.0109	0.0233	CbGeAlD
Clodronate—SLC25A5—spinal cord—Parkinson's disease	0.0107	0.0228	CbGeAlD
Clodronate—SLC25A6—nervous system—Parkinson's disease	0.0103	0.022	CbGeAlD
Clodronate—SLC25A4—midbrain—Parkinson's disease	0.0102	0.0219	CbGeAlD
Clodronate—SLC25A4—spinal cord—Parkinson's disease	0.00999	0.0213	CbGeAlD
Clodronate—SLC25A6—central nervous system—Parkinson's disease	0.00994	0.0212	CbGeAlD
Clodronate—SLC25A6—cerebellum—Parkinson's disease	0.00972	0.0207	CbGeAlD
Clodronate—SLC25A5—head—Parkinson's disease	0.00947	0.0202	CbGeAlD
Clodronate—SLC25A5—nervous system—Parkinson's disease	0.00898	0.0192	CbGeAlD
Clodronate—SLC25A4—head—Parkinson's disease	0.00888	0.019	CbGeAlD
Clodronate—SLC25A5—central nervous system—Parkinson's disease	0.00865	0.0185	CbGeAlD
Clodronate—SLC25A5—cerebellum—Parkinson's disease	0.00845	0.018	CbGeAlD
Clodronate—SLC25A4—nervous system—Parkinson's disease	0.00842	0.018	CbGeAlD
Clodronate—SLC25A4—central nervous system—Parkinson's disease	0.0081	0.0173	CbGeAlD
Clodronate—SLC25A4—cerebellum—Parkinson's disease	0.00792	0.0169	CbGeAlD
Clodronate—SLC25A6—brain—Parkinson's disease	0.00789	0.0169	CbGeAlD
Clodronate—SLC25A5—brain—Parkinson's disease	0.00686	0.0147	CbGeAlD
Clodronate—SLC25A4—brain—Parkinson's disease	0.00643	0.0137	CbGeAlD
Clodronate—PTGS2—embryo—Parkinson's disease	0.00352	0.00752	CbGeAlD
Clodronate—PTGS2—forebrain—Parkinson's disease	0.00312	0.00665	CbGeAlD
Clodronate—PTGS2—cardiovascular system—Parkinson's disease	0.00263	0.00563	CbGeAlD
Clodronate—SLC25A6—Metabolism of proteins—RPL6—Parkinson's disease	0.00228	0.0043	CbGpPWpGaD
Clodronate—PTGS2—medulla oblongata—Parkinson's disease	0.00225	0.00481	CbGeAlD
Clodronate—SLC25A4—Integration of energy metabolism—INS—Parkinson's disease	0.00225	0.00423	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TALDO1—Parkinson's disease	0.00218	0.0041	CbGpPWpGaD
Clodronate—SLC25A6—Disease—OMD—Parkinson's disease	0.00218	0.0041	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—TALDO1—Parkinson's disease	0.00218	0.0041	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—OMD—Parkinson's disease	0.00218	0.0041	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00217	0.00407	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00215	0.00405	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TAF1—Parkinson's disease	0.0021	0.00395	CbGpPWpGaD
Clodronate—SLC25A5—Disease—FBP1—Parkinson's disease	0.0021	0.00395	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NDUFB11—Parkinson's disease	0.00207	0.00389	CbGpPWpGaD
Clodronate—PTGS2—midbrain—Parkinson's disease	0.00206	0.00439	CbGeAlD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00205	0.00385	CbGpPWpGaD
Clodronate—PTGS2—spinal cord—Parkinson's disease	0.00201	0.00429	CbGeAlD
Clodronate—SLC25A6—Metabolism of proteins—DCTN1—Parkinson's disease	0.00198	0.00373	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GCH1—Parkinson's disease	0.00197	0.00371	CbGpPWpGaD
Clodronate—SLC25A4—Disease—VPS35—Parkinson's disease	0.00195	0.00367	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MCCC1—Parkinson's disease	0.00194	0.00366	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ND3—Parkinson's disease	0.00194	0.00366	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—TALDO1—Parkinson's disease	0.00183	0.00344	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—OMD—Parkinson's disease	0.00183	0.00344	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MCCC1—Parkinson's disease	0.00181	0.00341	CbGpPWpGaD
Clodronate—PTGS2—head—Parkinson's disease	0.00178	0.00381	CbGeAlD
Clodronate—SLC25A4—Metabolism of proteins—RPL6—Parkinson's disease	0.00178	0.00335	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TAF1—Parkinson's disease	0.00176	0.00331	CbGpPWpGaD
Clodronate—SLC25A6—Disease—FBP1—Parkinson's disease	0.00176	0.00331	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—FBP1—Parkinson's disease	0.00176	0.00331	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—DBH—Parkinson's disease	0.00176	0.00331	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GBA—Parkinson's disease	0.00176	0.00331	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NDUFB11—Parkinson's disease	0.00173	0.00326	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—RPL23A—Parkinson's disease	0.00173	0.00326	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—RPL14—Parkinson's disease	0.00173	0.00326	CbGpPWpGaD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—Parkinson's disease	0.00173	0.00325	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TALDO1—Parkinson's disease	0.0017	0.0032	CbGpPWpGaD
Clodronate—SLC25A4—Disease—OMD—Parkinson's disease	0.0017	0.0032	CbGpPWpGaD
Clodronate—PTGS2—nervous system—Parkinson's disease	0.00169	0.00361	CbGeAlD
Clodronate—SLC25A4—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00169	0.00318	CbGpPWpGaD
Clodronate—SLC25A5—Disease—RPL6—Parkinson's disease	0.00168	0.00316	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SNCA—Parkinson's disease	0.00168	0.00316	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GCH1—Parkinson's disease	0.00165	0.00311	CbGpPWpGaD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Parkinson's disease	0.00163	0.00307	CbGpPWpGaD
Clodronate—PTGS2—central nervous system—Parkinson's disease	0.00163	0.00348	CbGeAlD
Clodronate—SLC25A6—Metabolism of proteins—RPS8—Parkinson's disease	0.00161	0.00304	CbGpPWpGaD
Clodronate—PTGS2—cerebellum—Parkinson's disease	0.00159	0.0034	CbGeAlD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00159	0.00298	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—DCTN1—Parkinson's disease	0.00155	0.00291	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MCCC1—Parkinson's disease	0.00152	0.00285	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ND3—Parkinson's disease	0.00152	0.00285	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GBA—Parkinson's disease	0.00147	0.00277	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—FBP1—Parkinson's disease	0.00147	0.00277	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—DBH—Parkinson's disease	0.00147	0.00277	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—TALDO1—Parkinson's disease	0.00143	0.00268	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—OMD—Parkinson's disease	0.00143	0.00268	CbGpPWpGaD
Clodronate—SLC25A6—Disease—RPL6—Parkinson's disease	0.00141	0.00264	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SNCA—Parkinson's disease	0.00141	0.00264	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TAF1—Parkinson's disease	0.00137	0.00258	CbGpPWpGaD
Clodronate—SLC25A4—Disease—FBP1—Parkinson's disease	0.00137	0.00258	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MAG—Parkinson's disease	0.00136	0.00256	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—GDNF—Parkinson's disease	0.00136	0.00256	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NDUFB11—Parkinson's disease	0.00135	0.00254	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—RPL23A—Parkinson's disease	0.00135	0.00254	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—RPL14—Parkinson's disease	0.00135	0.00254	CbGpPWpGaD
Clodronate—PTGS2—brain—Parkinson's disease	0.00129	0.00276	CbGeAlD
Clodronate—SLC25A4—Metabolism—GCH1—Parkinson's disease	0.00129	0.00243	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—DDC—Parkinson's disease	0.00129	0.00243	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—VIM—Parkinson's disease	0.00128	0.00241	CbGpPWpGaD
Clodronate—SLC25A5—Disease—RPL23A—Parkinson's disease	0.00127	0.00239	CbGpPWpGaD
Clodronate—SLC25A5—Disease—RPL14—Parkinson's disease	0.00127	0.00239	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—RPS8—Parkinson's disease	0.00126	0.00237	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—PDYN—Parkinson's disease	0.00125	0.00234	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTA4—Parkinson's disease	0.00122	0.00229	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00121	0.00228	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00121	0.00228	CbGpPWpGaD
Clodronate—SLC25A5—Disease—RPS8—Parkinson's disease	0.00119	0.00223	CbGpPWpGaD
Clodronate—SLC25A5—Disease—FGF20—Parkinson's disease	0.00119	0.00223	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—GFAP—Parkinson's disease	0.00117	0.0022	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GBA—Parkinson's disease	0.00115	0.00216	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—DBH—Parkinson's disease	0.00115	0.00216	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—FBP1—Parkinson's disease	0.00115	0.00216	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00115	0.00216	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—PLA2G6—Parkinson's disease	0.00112	0.00211	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SNCA—Parkinson's disease	0.0011	0.00206	CbGpPWpGaD
Clodronate—SLC25A4—Disease—RPL6—Parkinson's disease	0.0011	0.00206	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PLA2G6—Parkinson's disease	0.0011	0.00206	CbGpPWpGaD
Clodronate—PTGS2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00109	0.00205	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MAOB—Parkinson's disease	0.00109	0.00204	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—DDC—Parkinson's disease	0.00108	0.00203	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—HSPA8—Parkinson's disease	0.00107	0.00201	CbGpPWpGaD
Clodronate—SLC25A6—Disease—RPL23A—Parkinson's disease	0.00107	0.002	CbGpPWpGaD
Clodronate—SLC25A6—Disease—RPL14—Parkinson's disease	0.00107	0.002	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Parkinson's disease	0.00106	0.00199	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTA4—Parkinson's disease	0.00102	0.00192	CbGpPWpGaD
Clodronate—SLC25A6—Disease—FGF20—Parkinson's disease	0.000994	0.00187	CbGpPWpGaD
Clodronate—SLC25A6—Disease—RPS8—Parkinson's disease	0.000994	0.00187	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—IGF2—Parkinson's disease	0.000963	0.00181	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—Parkinson's disease	0.000938	0.00176	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PLA2G6—Parkinson's disease	0.000919	0.00173	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MAOB—Parkinson's disease	0.00091	0.00171	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000881	0.00166	CbGpPWpGaD
Clodronate—SLC25A5—Disease—ADRBK1—Parkinson's disease	0.000872	0.00164	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HSPA1A—Parkinson's disease	0.000865	0.00163	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—DDC—Parkinson's disease	0.000844	0.00159	CbGpPWpGaD
Clodronate—SLC25A4—Disease—RPL23A—Parkinson's disease	0.000832	0.00156	CbGpPWpGaD
Clodronate—SLC25A4—Disease—RPL14—Parkinson's disease	0.000832	0.00156	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000826	0.00155	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYP2D6—Parkinson's disease	0.000807	0.00152	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.000806	0.00152	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTA4—Parkinson's disease	0.000797	0.0015	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CTGF—Parkinson's disease	0.000792	0.00149	CbGpPWpGaD
Clodronate—SLC25A4—Disease—FGF20—Parkinson's disease	0.000776	0.00146	CbGpPWpGaD
Clodronate—SLC25A4—Disease—RPS8—Parkinson's disease	0.000776	0.00146	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—IL6—Parkinson's disease	0.000757	0.00142	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—IGF2—Parkinson's disease	0.000752	0.00141	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—GSTM1—Parkinson's disease	0.000751	0.00141	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYP2E1—Parkinson's disease	0.000738	0.00139	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ADRBK1—Parkinson's disease	0.00073	0.00137	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NQO1—Parkinson's disease	0.00073	0.00137	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.000726	0.00137	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HSPA1A—Parkinson's disease	0.000725	0.00136	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—TH—Parkinson's disease	0.000719	0.00135	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PLA2G6—Parkinson's disease	0.000718	0.00135	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000711	0.00134	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MAOB—Parkinson's disease	0.00071	0.00134	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.000693	0.0013	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CYCS—Parkinson's disease	0.000691	0.0013	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000685	0.00129	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP2D6—Parkinson's disease	0.000676	0.00127	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CTGF—Parkinson's disease	0.000664	0.00125	CbGpPWpGaD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Parkinson's disease	0.000645	0.00121	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—INS—Parkinson's disease	0.000639	0.0012	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.000639	0.0012	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP2E1—Parkinson's disease	0.000619	0.00116	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—COMT—Parkinson's disease	0.000612	0.00115	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NQO1—Parkinson's disease	0.000612	0.00115	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTP1—Parkinson's disease	0.000609	0.00114	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MAOA—Parkinson's disease	0.000607	0.00114	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—TH—Parkinson's disease	0.000603	0.00113	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—HMOX1—Parkinson's disease	0.0006	0.00113	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—BDNF—Parkinson's disease	0.000599	0.00113	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—Parkinson's disease	0.000595	0.00112	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MTHFR—Parkinson's disease	0.00059	0.00111	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYCS—Parkinson's disease	0.000579	0.00109	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ABCB1—Parkinson's disease	0.000576	0.00108	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ADRBK1—Parkinson's disease	0.00057	0.00107	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HSPA1A—Parkinson's disease	0.000566	0.00106	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GSTM1—Parkinson's disease	0.000559	0.00105	CbGpPWpGaD
Clodronate—SLC25A5—Disease—APOE—Parkinson's disease	0.00055	0.00103	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GPX1—Parkinson's disease	0.000536	0.00101	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP2D6—Parkinson's disease	0.000528	0.000993	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CTGF—Parkinson's disease	0.000518	0.000975	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—COMT—Parkinson's disease	0.000513	0.000964	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00051	0.00096	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTP1—Parkinson's disease	0.00051	0.000959	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MAOA—Parkinson's disease	0.000509	0.000957	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—INS—Parkinson's disease	0.000508	0.000956	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—HMOX1—Parkinson's disease	0.000503	0.000946	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—INS—Parkinson's disease	0.000499	0.000939	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MTHFR—Parkinson's disease	0.000495	0.00093	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MTHFR—Parkinson's disease	0.000494	0.00093	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ABCB1—Parkinson's disease	0.000483	0.000908	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP2E1—Parkinson's disease	0.000483	0.000908	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NQO1—Parkinson's disease	0.000477	0.000898	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—TH—Parkinson's disease	0.000471	0.000885	CbGpPWpGaD
Clodronate—SLC25A5—Disease—INS—Parkinson's disease	0.00047	0.000883	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GSTM1—Parkinson's disease	0.000469	0.000882	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000462	0.00087	CbGpPWpGaD
Clodronate—SLC25A6—Disease—APOE—Parkinson's disease	0.000461	0.000866	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—APOE—Parkinson's disease	0.00046	0.000866	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYCS—Parkinson's disease	0.000452	0.00085	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GPX1—Parkinson's disease	0.000449	0.000844	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Parkinson's disease	0.000433	0.000814	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MTHFR—Parkinson's disease	0.000414	0.000779	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000414	0.000778	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000408	0.000766	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.000401	0.000754	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—COMT—Parkinson's disease	0.0004	0.000753	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTP1—Parkinson's disease	0.000398	0.000749	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MAOA—Parkinson's disease	0.000397	0.000747	CbGpPWpGaD
Clodronate—SLC25A6—Disease—INS—Parkinson's disease	0.000393	0.00074	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—INS—Parkinson's disease	0.000393	0.000739	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—HMOX1—Parkinson's disease	0.000393	0.000739	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTHFR—Parkinson's disease	0.000386	0.000726	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOE—Parkinson's disease	0.000386	0.000725	CbGpPWpGaD
Clodronate—PTGS2—Disease—VPS35—Parkinson's disease	0.000385	0.000725	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000379	0.000713	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCB1—Parkinson's disease	0.000377	0.000709	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTM1—Parkinson's disease	0.000366	0.000688	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000362	0.00068	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOE—Parkinson's disease	0.00036	0.000676	CbGpPWpGaD
Clodronate—PTGS2—Disease—MCCC1—Parkinson's disease	0.000358	0.000674	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GPX1—Parkinson's disease	0.00035	0.000659	CbGpPWpGaD
Clodronate—PTGS2—Disease—TALDO1—Parkinson's disease	0.000337	0.000633	CbGpPWpGaD
Clodronate—PTGS2—Disease—OMD—Parkinson's disease	0.000337	0.000633	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—INS—Parkinson's disease	0.00033	0.00062	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MTHFR—Parkinson's disease	0.000323	0.000608	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000319	0.000599	CbGpPWpGaD
Clodronate—SLC25A4—Disease—INS—Parkinson's disease	0.000307	0.000578	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOE—Parkinson's disease	0.000301	0.000566	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—Parkinson's disease	0.0003	0.000564	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ND3—Parkinson's disease	0.0003	0.000564	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MCCC1—Parkinson's disease	0.0003	0.000564	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CASP3—Parkinson's disease	0.000299	0.000563	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—OMD—Parkinson's disease	0.000282	0.00053	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TALDO1—Parkinson's disease	0.000282	0.00053	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000275	0.000518	CbGpPWpGaD
Clodronate—PTGS2—Disease—FBP1—Parkinson's disease	0.000271	0.000511	CbGpPWpGaD
Clodronate—PTGS2—Disease—TAF1—Parkinson's disease	0.000271	0.000511	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NDUFB11—Parkinson's disease	0.000267	0.000503	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—INS—Parkinson's disease	0.000257	0.000484	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCH1—Parkinson's disease	0.000255	0.00048	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00023	0.000433	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FBP1—Parkinson's disease	0.000227	0.000428	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DBH—Parkinson's disease	0.000227	0.000428	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GBA—Parkinson's disease	0.000227	0.000428	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000222	0.000418	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	0.000218	0.000409	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPL6—Parkinson's disease	0.000217	0.000408	CbGpPWpGaD
Clodronate—PTGS2—Disease—SNCA—Parkinson's disease	0.000217	0.000408	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—Parkinson's disease	0.000205	0.000386	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000204	0.000383	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000187	0.000352	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	0.000176	0.00033	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—Parkinson's disease	0.000172	0.000323	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DDC—Parkinson's disease	0.000167	0.000314	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPL23A—Parkinson's disease	0.000164	0.000309	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPL14—Parkinson's disease	0.000164	0.000309	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTA4—Parkinson's disease	0.000158	0.000296	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000156	0.000293	CbGpPWpGaD
Clodronate—PTGS2—Disease—RPS8—Parkinson's disease	0.000153	0.000288	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF20—Parkinson's disease	0.000153	0.000288	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000148	0.000278	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLA2G6—Parkinson's disease	0.000142	0.000267	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MAOB—Parkinson's disease	0.00014	0.000264	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—Parkinson's disease	0.000134	0.000252	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000134	0.000251	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADRBK1—Parkinson's disease	0.000113	0.000212	CbGpPWpGaD
Clodronate—PTGS2—Disease—HSPA1A—Parkinson's disease	0.000112	0.00021	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2D6—Parkinson's disease	0.000104	0.000196	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CTGF—Parkinson's disease	0.000102	0.000193	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2E1—Parkinson's disease	9.55e-05	0.00018	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NQO1—Parkinson's disease	9.44e-05	0.000178	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TH—Parkinson's disease	9.3e-05	0.000175	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYCS—Parkinson's disease	8.93e-05	0.000168	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—COMT—Parkinson's disease	7.91e-05	0.000149	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTP1—Parkinson's disease	7.87e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MAOA—Parkinson's disease	7.85e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—Parkinson's disease	7.76e-05	0.000146	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—Parkinson's disease	7.64e-05	0.000144	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—Parkinson's disease	7.45e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM1—Parkinson's disease	7.24e-05	0.000136	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOE—Parkinson's disease	7.11e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX1—Parkinson's disease	6.93e-05	0.00013	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—Parkinson's disease	6.39e-05	0.00012	CbGpPWpGaD
Clodronate—PTGS2—Disease—INS—Parkinson's disease	6.07e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOE—Parkinson's disease	5.95e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—INS—Parkinson's disease	5.09e-05	9.56e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—Parkinson's disease	2.65e-05	4.99e-05	CbGpPWpGaD
